Brain region-specific changes in oxidative stress and neurotrophin levels in autism spectrum disorders (ASD)
- PMID: 20967576
- DOI: 10.1007/s12311-010-0223-4
Brain region-specific changes in oxidative stress and neurotrophin levels in autism spectrum disorders (ASD)
Abstract
Autism spectrum disorders (ASD) are a group of neurodevelopmental disorders characterized by social and language deficits, stereotypic behavior, and abnormalities in motor functions. The particular set of behavioral impairments expressed in any given individual is variable across the spectrum. These behavioral abnormalities are consistent with our current understanding of the neuropathology of ASD which suggests abnormalities in the amygdala, temporal and frontal cortexes, hippocampus, and cerebellum. However, regions unrelated to these behavioral deficits appear largely intact. Both genetic predisposition and environmental toxins and toxicants have been implicated in the etiology of autism; the impact of these environmental triggers is associated with increases in oxidative stress, and is further exacerbated when combined with genetic susceptibility. We have previously reported increased levels of 3-nitrotyrosine (3-NT), a marker of oxidative stress, in ASD cerebella. We have also shown that this increase was associated with an elevation in neurotrophin-3 (NT-3) levels. The objectives of the current study were to determine whether the increase in oxidative stress in ASD is brain region-specific, to identify the specific brain regions affected by oxidative stress, and to compare brain region-specific NT-3 expression between ASD and control cases. The levels of 3-NT and NT-3 were measured with specific ELISAs in individual brain regions of two autistic and age- and postmortem interval (PMI)--matched control donors. In the control brain, the levels of 3-NT were uniformly low in all brain regions examined ranging from 1.6 to 12.0 pmol/g. On the other hand, there was a great variation in 3-NT levels between individual brain regions of the autistic brains ranging from 1.7 to 281.2 pmol/g. The particular brain regions with the increased 3-NT and the magnitude of the increase were both different in the two autistic cases. In the older autistic case, the brain regions with highest levels of 3-NT included the orbitofrontal cortex (214.5 pmol/g), Wernicke's area (171.7 pmol/g), cerebellar vermis (81.2 pmol/g), cerebellar hemisphere (37.2 pmol/g), and pons (13.6 pmol/g); these brain areas are associated with the speech processing, sensory and motor coordination, emotional and social behavior, and memory. Brain regions that showed 3-NT increase in both autistic cases included the cerebellar hemispheres and putamen. Consistent with our earlier report, we found an increase in NT-3 levels in the cerebellar hemisphere in both autistic cases. We also detected an increase in NT-3 level in the dorsolateral prefrontal cortex (BA46) in the older autistic case and in the Wernicke's area and cingulate gyrus in the younger case. These preliminary results reveal, for the first time, brain region-specific changes in oxidative stress marker 3-NT and neurotrophin-3 levels in ASD.
Similar articles
-
Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism.Cerebellum. 2009 Sep;8(3):366-72. doi: 10.1007/s12311-009-0105-9. Epub 2009 Apr 9. Cerebellum. 2009. PMID: 19357934
-
Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas.Arch Neurol. 2000 Jun;57(6):846-51. doi: 10.1001/archneur.57.6.846. Arch Neurol. 2000. PMID: 10867782
-
Cellular stress and apoptosis contribute to the pathogenesis of autism spectrum disorder.Autism Res. 2018 Jul;11(7):1076-1090. doi: 10.1002/aur.1966. Epub 2018 May 15. Autism Res. 2018. PMID: 29761862 Free PMC article.
-
A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures.Mol Psychiatry. 2012 Apr;17(4):389-401. doi: 10.1038/mp.2011.165. Epub 2011 Dec 6. Mol Psychiatry. 2012. PMID: 22143005 Free PMC article. Review.
-
Developmentally regulated Ca2+-dependent activator protein for secretion 2 (CAPS2) is involved in BDNF secretion and is associated with autism susceptibility.Cerebellum. 2009 Sep;8(3):312-22. doi: 10.1007/s12311-009-0097-5. Epub 2009 Feb 24. Cerebellum. 2009. PMID: 19238500 Review.
Cited by
-
The Neuroprotective Effects of Astaxanthin: Therapeutic Targets and Clinical Perspective.Molecules. 2019 Jul 20;24(14):2640. doi: 10.3390/molecules24142640. Molecules. 2019. PMID: 31330843 Free PMC article. Review.
-
Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism.Front Physiol. 2014 Apr 22;5:150. doi: 10.3389/fphys.2014.00150. eCollection 2014. Front Physiol. 2014. PMID: 24795645 Free PMC article. Review.
-
Impaired Thiol/Disulfide Homeostasis in Children Diagnosed with Autism: A Case-Control Study.J Mol Neurosci. 2021 Jul;71(7):1394-1402. doi: 10.1007/s12031-021-01790-1. Epub 2021 Jan 12. J Mol Neurosci. 2021. PMID: 33433850
-
Perinatal stress, brain inflammation and risk of autism-review and proposal.BMC Pediatr. 2012 Jul 2;12:89. doi: 10.1186/1471-2431-12-89. BMC Pediatr. 2012. PMID: 22747567 Free PMC article. Review.
-
Evidence of neurodegeneration in autism spectrum disorder.Transl Neurodegener. 2013 Aug 8;2(1):17. doi: 10.1186/2047-9158-2-17. Transl Neurodegener. 2013. PMID: 23925007 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials